Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
2026-07-04 04:22:00 ET Biogen (NASDAQ: BIIB) built itself into a biotech giant thanks to its port
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.